Universal Biosensors (ASX:UBI) Cash-to-Debt : 2.06 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Universal Biosensors's cash to debt ratio for the quarter that ended in Dec. 2023 was 2.06.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Universal Biosensors could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Universal Biosensors's Cash-to-Debt or its related term are showing as below:

ASX:UBI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.71 Med: 3.72 Max: No Debt
Current: 2.06

During the past 13 years, Universal Biosensors's highest Cash to Debt Ratio was No Debt. The lowest was 0.71. And the median was 3.72.

ASX:UBI's Cash-to-Debt is ranked better than
50.7% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 1.875 vs ASX:UBI: 2.06

Universal Biosensors Cash-to-Debt Historical Data

The historical data trend for Universal Biosensors's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Universal Biosensors Cash-to-Debt Chart

Universal Biosensors Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

5.66

6.79

5.38

2.06

Universal Biosensors Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															5.38	3.89	3.30	3.68	2.06

Competitive Comparison of Universal Biosensors's Cash-to-Debt

For the Medical Devices subindustry, Universal Biosensors's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Biosensors's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Cash-to-Debt falls into.

Universal Biosensors Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Universal Biosensors's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10.24	/	(1.746	+	3.226)
	=	2.06

Universal Biosensors's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10.24	/	(1.746	+	3.226)
	=	2.06

Universal Biosensors (ASX:UBI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Universal Biosensors Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Biosensors (ASX:UBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Corporate Avenue, Rowville, VIC, AUS, 3178

Website

https://www.universalbiosensors.com

Universal Biosensors Inc is a developer of biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in its hand-held portable analysers for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture, enabling high speed, ease of use, reliability, accuracy at low cost.

Universal Biosensors (ASX:UBI) Headlines

No Headlines